Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study

NCT02271165 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Difficult recruitment

Conditions

Dermatomyositis

Interventions

DRUG: Immunoglobulin (Hizentra)

Sponsor

Thomas Jefferson University